JP2019516375A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516375A5
JP2019516375A5 JP2018560186A JP2018560186A JP2019516375A5 JP 2019516375 A5 JP2019516375 A5 JP 2019516375A5 JP 2018560186 A JP2018560186 A JP 2018560186A JP 2018560186 A JP2018560186 A JP 2018560186A JP 2019516375 A5 JP2019516375 A5 JP 2019516375A5
Authority
JP
Japan
Prior art keywords
allele
pos
nuclear position
snp
nuclear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018560186A
Other languages
English (en)
Japanese (ja)
Other versions
JP7475811B2 (ja
JP2019516375A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/033625 external-priority patent/WO2017201461A1/en
Publication of JP2019516375A publication Critical patent/JP2019516375A/ja
Publication of JP2019516375A5 publication Critical patent/JP2019516375A5/ja
Priority to JP2022044738A priority Critical patent/JP7392020B2/ja
Priority to JP2023213224A priority patent/JP2024037945A/ja
Application granted granted Critical
Publication of JP7475811B2 publication Critical patent/JP7475811B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018560186A 2016-05-20 2017-05-19 遺伝子に基づく炎症性腸疾患の診断 Active JP7475811B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022044738A JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662339357P 2016-05-20 2016-05-20
US62/339,357 2016-05-20
PCT/US2017/033625 WO2017201461A1 (en) 2016-05-20 2017-05-19 Diagnosis of inflammatory bowel disease based on genes

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2022044738A Division JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Division JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断

Publications (3)

Publication Number Publication Date
JP2019516375A JP2019516375A (ja) 2019-06-20
JP2019516375A5 true JP2019516375A5 (cg-RX-API-DMAC7.html) 2020-06-18
JP7475811B2 JP7475811B2 (ja) 2024-04-30

Family

ID=60326226

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018560186A Active JP7475811B2 (ja) 2016-05-20 2017-05-19 遺伝子に基づく炎症性腸疾患の診断
JP2022044738A Active JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Pending JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022044738A Active JP7392020B2 (ja) 2016-05-20 2022-03-18 遺伝子に基づく炎症性腸疾患の診断
JP2023213224A Pending JP2024037945A (ja) 2016-05-20 2023-12-18 遺伝子に基づく炎症性腸疾患の診断

Country Status (6)

Country Link
US (2) US11549146B2 (cg-RX-API-DMAC7.html)
EP (1) EP3458466B1 (cg-RX-API-DMAC7.html)
JP (3) JP7475811B2 (cg-RX-API-DMAC7.html)
KR (4) KR20190016972A (cg-RX-API-DMAC7.html)
CN (2) CN117286238A (cg-RX-API-DMAC7.html)
WO (1) WO2017201461A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
KR20240095481A (ko) 2016-03-17 2024-06-25 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법
EP3458466B1 (en) * 2016-05-20 2024-08-07 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease based on genes
KR20220088529A (ko) 2019-05-14 2022-06-27 프로메테우스 바이오사이언시즈, 인크. Tl1a 환자 선택 방법, 시스템 및 장치
WO2021260577A2 (en) * 2020-06-26 2021-12-30 Pfizer Inc. Methods of treating inflammatory bowel disease with tl1a antibodies
PH12023500011A1 (en) * 2020-11-13 2024-03-11 Cedars Sinai Medical Center Methods, systems, and kits for treatment of inflammatory diseases targeting tl1a
CN115851911B (zh) * 2022-11-25 2025-10-24 南京鼓楼医院 一种用于鉴别狼疮性肾炎的尿液外泌体tsRNA标志物和探针及其应用
EP4646434A2 (en) * 2023-01-06 2025-11-12 Prometheus Biosciences, Inc. Methods of treating inflammatory diseases with combination of tl1a inhibitors and tnf inhibitors
WO2025038473A1 (en) 2023-08-11 2025-02-20 Paragon Therapeutics, Inc. Tl1a binding antibodies and methods of use

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443421A (en) 1982-03-16 1984-04-17 Occidental Chemical Corporation Process for removing particulate impurities from aqueous phosphoric acid
DE3475880D1 (en) 1984-08-27 1989-02-09 Toray Industries Solid-liquid separating apparatus
US5000850A (en) 1986-09-10 1991-03-19 Engelhard Corporation Apparatus for dewatering an aqueous clay suspension
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US7357927B2 (en) 1996-03-12 2008-04-15 Human Genome Sciences, Inc. Death domain containing receptors
AU5052899A (en) * 1998-07-25 2000-02-21 Astrazeneca Ab Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
JP2004194534A (ja) 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
EP1673473B1 (en) * 2003-10-06 2011-07-06 Novartis AG Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease
AU2005300688B2 (en) 2004-11-03 2012-02-02 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
JP5065253B2 (ja) 2005-05-06 2012-10-31 ザイモジェネティクス， インコーポレイテッド Ｉｌ−３１モノクローナル抗体とその使用法
WO2006127900A2 (en) 2005-05-25 2006-11-30 Biogen Idec Ma Inc. Tl1a in the treatment of disease
EP1963534A2 (en) * 2005-12-19 2008-09-03 Genizon Biosciences Inc. Genemap of the human gene associated with crohn's disease
US20090018031A1 (en) 2006-12-07 2009-01-15 Switchgear Genomics Transcriptional regulatory elements of biological pathways tools, and methods
US20110217310A1 (en) 2007-01-10 2011-09-08 Siegel Richard M Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
US20100190162A1 (en) 2007-02-26 2010-07-29 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
WO2008106579A2 (en) 2007-02-28 2008-09-04 Cedars-Sinai Medical Center The role of il-12, il-23 and il-17 receptors in inflammatory bowel disease
US20150376707A1 (en) 2007-05-18 2015-12-31 Cedars-Sinai Medical Center Methods of diagnosing and treating inflammatory bowel disease
US8118175B2 (en) 2007-07-18 2012-02-21 Siemens Industry, Inc. Venting device for a disc filter
WO2009039244A2 (en) * 2007-09-18 2009-03-26 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease
WO2009052512A2 (en) * 2007-10-19 2009-04-23 Cedars-Sinai Medical Center Methods of using genetic variants to diagnose and predict inflammatory bowel disease
EP2500362A3 (en) 2007-11-13 2012-10-24 Teva Biopharmaceuticals USA, Inc. Humanized antibodies against TL1A
HRP20140709T1 (hr) * 2008-08-12 2014-09-26 Zinfandel Pharmaceuticals, Inc. Postupak identifikacije faktora rizika za alzheimerovu bolest
WO2010025340A2 (en) 2008-08-29 2010-03-04 Centocor Ortho Biotech Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
JP2010088432A (ja) 2008-09-09 2010-04-22 Kansetsu Saisei Kenkyusho:Kk Ｔｎｆ阻害薬治療による有効性・副作用発現に関する多型、およびその利用
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
WO2010075579A2 (en) 2008-12-24 2010-07-01 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
AU2010236568B2 (en) 2009-04-14 2015-08-27 Société des Produits Nestlé S.A. Inflammatory bowel disease prognostics
US20130136720A1 (en) 2010-01-15 2013-05-30 Cedars-Sinai Medical Center Methods of using fut2 genetic variants to diagnose crohn's disease
WO2011153501A2 (en) * 2010-06-04 2011-12-08 Prometheus Laboratories Inc. Methods for improving inflammatory bowel disease diagnosis
US8766034B2 (en) 2010-09-22 2014-07-01 Cedars-Sinai Medical Center TL1A model of inflammation fibrosis and autoimmunity
DK2638163T3 (en) 2010-11-12 2017-07-24 Massachusetts Gen Hospital POLYCOMB-ASSOCIATED NON-CODING RNAs
US9902996B2 (en) 2011-02-11 2018-02-27 Cedars-Sinai Medical Center Methods of predicting the need for surgery in crohn's disease
MX362132B (es) 2011-05-10 2019-01-07 Nestec Sa Metodos para perfilado de actividad de enfermedad para manejo de terapia personalizado.
EP2710147A1 (en) 2011-05-18 2014-03-26 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of acute myeloid leukemia
WO2012161856A1 (en) 2011-05-20 2012-11-29 Government Of The United States, As Represented By The Secretary, Department Of Health And Human Services Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
BR112013030958B1 (pt) 2011-06-03 2022-02-08 Xoma Technology Ltd Anticorpo que se liga ao fator de transformação de crescimento beta, composição farmacêutica, usos dos mesmos, molécula de ácido nucleico, vetor de expressão, e método para produção de um anticorpo
JP2015502740A (ja) 2011-10-21 2015-01-29 ネステク ソシエテ アノニム 炎症性腸疾患の診断を改善するための方法
MX2014009490A (es) * 2012-02-10 2014-08-29 Novo Nordisk As Metodos relacionados con el tratamiento de enfermedades y trastornos inflamatorios.
WO2014160883A1 (en) 2013-03-27 2014-10-02 Cedars-Sinai Medical Center Treating fibrosis and inflammation by inhibiting tl1a
EP3498867B1 (en) 2013-05-17 2021-09-29 Cedars-Sinai Medical Center Variants of tnfsf15 and dcr3 associated with crohn's disease
KR102259588B1 (ko) * 2013-10-09 2021-06-02 세다르스-신나이 메디칼 센터 과민성 장 증후군 및 염증성 장 질환의 진단 및 치료
WO2015138774A1 (en) * 2014-03-13 2015-09-17 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2016170348A2 (en) 2015-04-22 2016-10-27 Mina Therapeutics Limited Sarna compositions and methods of use
AU2017222654B2 (en) 2016-02-26 2021-07-08 Nanotech Energy, Inc. Methods, devices and systems for processing of carbonaceous compositions
EP3458466B1 (en) * 2016-05-20 2024-08-07 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease based on genes
WO2018022982A1 (en) 2016-07-29 2018-02-01 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
US10322174B2 (en) 2016-10-26 2019-06-18 Cedars-Sinai Medical Center Neutralizing anti-TL1A monoclonal antibodies
WO2018204764A1 (en) 2017-05-05 2018-11-08 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
US11675142B2 (en) 2018-12-14 2023-06-13 Fujikura Ltd. Ferrule, fiber-equipped ferrule, and method for manufacturing fiber-equipped ferrule

Similar Documents

Publication Publication Date Title
JP2019516375A5 (cg-RX-API-DMAC7.html)
JP2012080900A5 (cg-RX-API-DMAC7.html)
JP2012503985A5 (cg-RX-API-DMAC7.html)
JP2018038436A5 (cg-RX-API-DMAC7.html)
JP2016041070A5 (cg-RX-API-DMAC7.html)
CA2938731A1 (en) Methods of treating alzheimer's disease
JP2017507130A5 (cg-RX-API-DMAC7.html)
JP2013532494A5 (cg-RX-API-DMAC7.html)
JP2014533949A5 (cg-RX-API-DMAC7.html)
JP2011528903A5 (cg-RX-API-DMAC7.html)
RU2018122965A (ru) Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания
JP2010528590A5 (cg-RX-API-DMAC7.html)
JP2013544536A5 (cg-RX-API-DMAC7.html)
JP2009526524A5 (cg-RX-API-DMAC7.html)
Schorderet et al. IROme, a New High‐Throughput Molecular Tool for the Diagnosis of Inherited Retinal Dystrophies
Ortiz et al. Electrochemical detection of single-nucleotide polymorphism associated with rifampicin resistance in Mycobacterium tuberculosis using solid-phase primer elongation with ferrocene-linked redox-labeled nucleotides
Jauset-Rubio et al. Solid-phase primer elongation using biotinylated dNTPs for the detection of a single nucleotide polymorphism from a fingerprick blood sample
JP2020092721A5 (cg-RX-API-DMAC7.html)
Sloane et al. Rapid KRAS mutation detection via hybridization-induced aggregation of microbeads
KR101287431B1 (ko) 표적 유전자의 다양한 변이가 존재하는 유전자 영역을 증폭하기 위한 프라이머 조성물, 이를 이용한 표적 유전자 증폭 방법 및 이를 포함하는 ｐｃｒ 증폭 키트 그리고 이를 이용한 표적 유전자의 유전자형 분석방법
Randhawa et al. A novel Tetra-primer ARMS-PCR based assay for genotyping SNP rs12303764 (G/T) of human Unc-51 like kinase 1 gene
JP2008306974A (ja) Ｈｃｖ遺伝子型判定方法、並びに、これに用いるｌｎａプローブ及びキット
Niihara et al. Simple and rapid detection of HLA-A* 31: 01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method
Delvaux et al. Comparison of four methods of genotyping IL28B polymorphisms in chronic hepatitis C patients
CN107988361A (zh) 诊断子宫颈癌或评估子宫颈癌风险的方法和试剂盒